The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis

Klaus P. Machold, Robert Landewe, Josef S. Smolen, Tanja A. Stamm, Desiree M. van der Heijde, Kirsten N. Verpoort, Kerstin Brickmann, Janitzia Vazquez-Mellado, Dimitri E. Karateev, Ferdinand C. Breedveld, Paul Emery, Thomas W. J. Huizinga

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)495-502
JournalAnnals of the Rheumatic Diseases
Volume69
Issue number3
DOIs
Publication statusPublished - Mar 2010

Cite this

Machold, K. P., Landewe, R., Smolen, J. S., Stamm, T. A., van der Heijde, D. M., Verpoort, K. N., Brickmann, K., Vazquez-Mellado, J., Karateev, D. E., Breedveld, F. C., Emery, P., & Huizinga, T. W. J. (2010). The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis. Annals of the Rheumatic Diseases, 69(3), 495-502. https://doi.org/10.1136/ard.2009.122473